Stock listing

OTC:KSPHF Kissei Pharmaceutical Co., Ltd. Stock

US listing (OTC) of Kissei Pharmaceutical Co., Ltd. · home listing Tokyo:4547

Follow Kissei Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.

Ticker: OTC:KSPHF
Asset type: Stock
Exchange: OTC
Currency: USD

What changed lately

Latest news release · Oct 29, 2026
Notice Concerning Revisions to Financial Results Forecast

Latest news

Notice Concerning Revisions to Financial Results Forecast

Oct 29, 2026

Announcement for the Results Report by the Council of Pharmaceutical Affairs (Mdical Product Second Section) on TAVNEOS

Oct 21, 2026

Notice Concerning Status of Acquisition of Treasury Shares

Oct 5, 2026

Notice of Completion of Payment for Treasury Shares Disposal as Restricted Stock for Employee Shareholding Association and Partial

Aug 10, 2026

Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]

Jul 31, 2026

Notice Regarding Completion of Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers

Jul 23, 2026

Announcement for the Opnion by European Authorities on TAVNEOS

Jun 28, 2026

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment

Oct 7, 2025

Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results

Aug 6, 2025

Issued by another party

Viridian Therapeutics Announces Collaboration and License Agreement with Kissei Pharmaceutical to Develop and Commercialize Veligrotug and VRDN-003 in Japan with an Upfront Payment of $70 Million and up to $315 Million in Milestone Payments

Jul 30, 2025

All Kissei Pharmaceutical Co., Ltd. news

Decks

Q2 FY2023 Earnings Presentation
Earnings · 28 slides · Nov 8, 2023
FY2022 Earnings Presentation
Earnings · 24 slides · May 10, 2023
Q2 FY2022 Earnings Presentation
Earnings · 20 slides · Nov 9, 2022

Kissei Pharmaceutical Co., Ltd. on 6ix

News releases: 9 in the last 12 months · 33 in all · newest Oct 29, 2026 · oldest 2017
Decks: 3 decks · latest Nov 8, 2023

Where Kissei Pharmaceutical Co., Ltd. is listed

Listing	Exchange	Country	Currency
Tokyo:4547 キッセイ薬品工業 · Home listing	Tokyo	Japan	JPY
OTC:KSPHF · This page	OTC	United States	USD

OTC:KSPHF Kissei Pharmaceutical Co., Ltd. Stock

What changed lately

Notice Concerning Revisions to Financial Results Forecast

Latest news

Notice Concerning Revisions to Financial Results Forecast

Announcement for the Results Report by the Council of Pharmaceutical Affairs (Mdical Product Second Section) on TAVNEOS

Notice Concerning Status of Acquisition of Treasury Shares

Notice of Completion of Payment for Treasury Shares Disposal as Restricted Stock for Employee Shareholding Association and Partial

Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]

Notice Regarding Completion of Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers

Announcement for the Opnion by European Authorities on TAVNEOS

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment

Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results

Viridian Therapeutics Announces Collaboration and License Agreement with Kissei Pharmaceutical to Develop and Commercialize Veligrotug and VRDN-003 in Japan with an Upfront Payment of $70 Million and up to $315 Million in Milestone Payments

Decks

Q2 FY2023 Earnings Presentation

FY2022 Earnings Presentation

Q2 FY2022 Earnings Presentation

Kissei Pharmaceutical Co., Ltd. on 6ix

Where Kissei Pharmaceutical Co., Ltd. is listed